Evasion of Type I Interferon by SARS-CoV-2

Cited by (958)

Items 501–600 of 958

1. Natural evidence of coronaviral 2′-O-methyltransferase activity affecting viral pathogenesis via improved substrate RNA binding
   Jikai Deng, Shimin Yang, Yingjian Li, Xue Tan, Jiejie Liu, Yanying Yu, Qiang Ding, Chengpeng Fan, Hongyun Wang, Xianyin Chen et al. · 2024 · Signal Transduction and Targeted Therapy
2. Insights into the modulation of the interferon response and NAD+in the context of COVID-19
   Nada J. Habeichi, Cynthia Tannous, Andriy Yabluchanskiy, Raffaele Altara, Mathias Mericskay, George W. Booz, Fouad Anthony Zouein · 2021 · International Reviews of Immunology
3. COVID-19 therapies: do we see substantial progress?
   Lucyna Matusewicz, Marlena Golec, Aleksander Czogalla, Kazimierz Kuliczkowski, Adam Konka, Joanna Zembala-John, Aleksander F. Sikorski · 2022 · Cellular & Molecular Biology Letters
4. Type I interferon signaling in SARS-CoV-2 associated neurocognitive disorder (SAND): Mapping host-virus interactions to an etiopathogenesis
   George D. Vavougios, Gabriel A. de Erausquin, Heather M. Snyder · 2022 · Frontiers in Neurology
5. Antiviral Nanobiologic Therapy Remodulates Innate Immune Responses to Highly Pathogenic Coronavirus
   Xuan Liu, Lunzhi Yuan, Jijing Chen, Yali Zhang, Peiwen Chen, Ming Zhou, Jiaxuan Xie, Jian Ma, Jianzhong Zhang, Kun Wu et al. · 2023 · Advanced Science
6. Rapid endothelial infection, endothelialitis and vascular damage characterise SARS-CoV-2 infection in a human lung-on-chip model
   Vivek V. Thacker, Kunal Sharma, Neeraj Dhar, Gian-Filippo Mancini, Jessica Sordet‐Dessimoz, John D. McKinney · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
7. Current Landscape of IFN-λ: Induction, Inhibition, and Potential Clinical Applications to Treat Respiratory Viral Infections
   Iván Martínez-Espinoza, Antonieta Guerrero-Plata · 2023 · ImmunoHorizons
8. Improvement of mucosal immunity by a live-attenuated SARS-CoV-2 nasal vaccine.
   J. Yeung, Tian Wang, Pei-Yong Shi · 2023 · Current Opinion in Virology
9. SARS-CoV-2 Membrane protein regulates the function of Spike by inhibiting its plasma membrane localization and enzymatic activity of Furin
   Qi Xiang, Jie Wu, Yuzheng Zhou, Linhao Li, Miao Tian, Guobao Li, Zheng Zhang, Yang Fu · 2024 · Microbiological Research
10. SADS-CoV nsp1 inhibits the STAT1 phosphorylation by promoting K11/K48-linked polyubiquitination of JAK1 and blocks the STAT1 acetylation by degrading CBP
    Yingjie Xiang, Chunxiao Mou, Liqi Zhu, Ziyan Wang, Kaichuang Shi, Wenbin Bao, Jiarui Li, Xiang Chen, Zhenhai Chen · 2024 · Journal of Biological Chemistry
11. The emerging role of SARS-CoV-2 nonstructural protein 1 (nsp1) in epigenetic regulation of host gene expression
    Konstantin I. Ivanov, Haibin Yang, Ruixue Sun, Chunmei Li, Deyin Guo · 2024 · FEMS Microbiology Reviews
12. MDA5 Is a Major Determinant of Developing Symptoms in Critically Ill COVID-19 Patients
    Amit K. Maiti · 2024 · Clinical Reviews in Allergy & Immunology
13. Linear ubiquitination mediates coronavirus NSP14-induced NF-κB activation
    Fang Hua, Wenzhuo Hao, Lingyan Wang, Kun Song, Abdul Hasan, Yakun Wu, Kevin Li, Zhen Lin, Yiwen Sun, Shitao Li · 2024 · Cell Communication and Signaling
14. Strategies Used by SARS-CoV-2 to Evade the Innate Immune System in an Evolutionary Perspective
    Hong Mei Fan, Mingfu Tian, Siyu Liu, Chenglin Ye, Zhiqiang Li, Kailang Wu, Chengliang Zhu · 2024 · Pathogens
15. SARS-CoV-2 Nsp15 endoribonuclease subverts host defenses to enhance viral fitness in lung cells
    Xiang Chi, Xueying Liang, Kishore Vaddadi, Xiaoming Zhang, Chaitanya Gandikota, Sunil More, Lin Liu, Xufang Deng · 2025 · Journal of Virology
16. The bittersweet link between glucose metabolism, cellular microenvironment and viral infection
    Xueao Liu, Li Chen, Honglin Niu, Yuhan Chen, Peiyao Chen, Lei Liu, Rui Wu · 2025 · Virulence
17. The IRF transcription factor family in type I interferon-mediated antiviral immunity and associated diseases
    Hideyuki Yanai, Tadatsugu Taniguchi · 2026 · Immunity & Inflammation
18. Establishment of a Rapid Detection System for ISG20-Dependent SARS-CoV-2 Subreplicon RNA Degradation Induced by Interferon-α
    Yutaka Furutani, Mariko Toguchi, Shoko Higuchi, Kaori Yanaka, Luc Gailhouste, Xian‐Yang Qin, Takahiro Masaki, Sae Ochi, Tomokazu Matsuura · 2021 · International Journal of Molecular Sciences
19. Coordinated regulation of interferon and inflammasome signaling pathways by SARS-CoV-2 proteins
    Na‐Eun Kim, Yoon‐Jae Song · 2022 · The Journal of Microbiology
20. An Overview of SARS-CoV-2 Molecular Diagnostics in Europe
    Emma Ann Davies, Hamzah Z. Farooq, Benjamin Brown, Peter Tilston, Ashley Kate McEwan, Andrew Birtles, Robert William O'Hara, Shazaad S. Y. Ahmad, Nicholas W. Machin, Louise M Hesketh et al. · 2022 · Clinics in Laboratory Medicine
21. Stimulation of interferon-β responses by aberrant SARS-CoV-2 small viral RNAs acting as retinoic acid-inducible gene-I agonists
    Yasuha Arai, Itaru Yamanaka, Toru Okamoto, Ayana Isobe, Naomi Nakai, Naoko Kamimura, Tatsuya Suzuki, Tomo Daidoji, Takao Ono, Takaaki Nakaya et al. · 2022 · iScience
22. The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
    Ana C. Puhl, Thomas R. Lane, Fabio Urbina, Sean Ekins · 2022 · Frontiers in Drug Discovery
23. Strategy To Assess Zoonotic Potential Reveals Low Risk Posed by SARS-Related Coronaviruses from Bat and Pangolin
    Yong Yang, Xu-Rui Shen, Yulan Zhang, Ren-Di Jiang, Xi Wang, Zhenqiong Guan, Qian Li, Yulin Yao, Qian-Chun Gong, Rong Geng et al. · 2023 · mBio
24. SARS-COV-2 protein NSP9 promotes cytokine production by targeting TBK1
    Yihua Zhang, Bowen Xin, Yinan Liu, Wenyi Jiang, Wendong Han, Jian Deng, Pei‐Hui Wang, Xiaowu Hong, Dapeng Yan · 2023 · Frontiers in Immunology
25. Deubiquitinase USP1 regulates sarbecovirus ORF6 protein function
    Wenying Gao, Liuli Wang, Wenzhe Cui, Hongfei Wang, Guofeng Huang, Zhaolong Li, Guangquan Li, Wenyan Zhang · 2023 · Journal of Virology
26. Type I and type III interferons: From basic biology and genetics to clinical development for COVID-19 and beyond
    Evangelos Andreakos · 2024 · Seminars in Immunology
27. Innate immunology in COVID-19—a living review. Part I: viral entry, sensing and evasion
    Clarissa R. Coveney, Michael Tellier, Fangfang Lu, Shayda Maleki-Toyserkani, Ruth E. Jones, Valentina M T Bart, Ellie Pring, Aljawharah Alrubayyi, Felix Clemens Richter, David Oliver Scourfield et al. · 2020 · Oxford Open Immunology
28. The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2
    Wael Alturaiki, Ayman Mubarak, Abduallah Al Jurayyan, Maged Gomaa Hemida · 2021 · Human Vaccines & Immunotherapeutics
29. Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency
    Nathan M. Markarian, Gaël Galli, Dhanesh Patel, Mark Hemmings, Priya Nagpal, Albert Marinus Berghuis, Levon G. Abrahamyan, Silvia Marina Vidal · 2022 · Frontiers in Microbiology
30. Molecular insights into onset of autoimmunity in SARS‐CoV‐2 infected patients
    Dama Laxminarayana · 2022 · Rheumatology & autoimmunity
31. Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics
    José Ednésio da Cruz Freire, José E. Monteiro-Júnior, Daniel Pascoalino Pinheiro, Grayce Ellen da Cruz Paiva Lima, Camila Lopes do Amaral, Victor Rezende Veras, Mayara Ponte Madeira, Erika Bastos Lima Freire, Renan Galvão Ozório, Virgínia Oliveira Fernandes et al. · 2022 · 3 Biotech
32. Nonstructural protein 1 widespread RNA decay phenotype varies among coronaviruses
    Yahaira Bermudez, Jacob Miles, Mandy Muller · 2022 · iScience
33. Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
    Denisa Bojková, Richard S. Stack, Tamara Rothenburger, Joshua D. Kandler, Sandra Ciesek, Mark N. Wass, Martin Michaelis, Jindrich Jr. Cinatl · 2022 · Journal of Infection
34. Swine acute diarrhea syndrome coronavirus Nsp1 suppresses IFN-λ1 production by degrading IRF1 via ubiquitin–proteasome pathway
    Chunhui Zhong, Gaoli She, Yu‐Kun Zhao, Yufang Liu, Jingmin Li, Xiaona Wei, Zexin Chen, Keyu Zhao, Zhiqing Zhao, Zhichao Xu et al. · 2024 · Veterinary Research
35. Dissecting the COVID ‐19 Immune Response: Unraveling the Pathways of Innate Sensing and Response to SARS ‐ CoV ‐2 Structural Proteins
    Matheus de Oliveira Silva Pinto, Leonardo de Paula Pereira, Ana Luiza Pessoa de Mendonça Angelo, Marcelo Antônio Pascoal-Xavier, Alexandre V. Machado, Remo Castro Russo · 2025 · Journal of Molecular Recognition
36. Live attenuated SARS-CoV-2 vaccine OTS-228 demonstrates efficacy, safety, and stability in preclinical model
    Tobias Britzke, Nico Joël Halwe, Lorenz Ulrich, Angele Breithaupt, G. Tuba Barut, Claudia Wylezich, Nadine Ebert, Bettina Salome Trüeb, Volker Thiel, Donata Hoffmann et al. · 2025 · npj Vaccines
37. Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic
    Xiang-Hui Li, Yabo Zhang, Libing He, Jiang Si, Shuai Qiu, Yuhua He, Jiacun Wei, Zhili Wang, Long-Xiang Xie, Yan-Zhang Li et al. · 2022 · International Journal on Biological Sciences
38. Deactivation of the antiviral state by rabies virus through targeting and accumulation of persistently phosphorylated STAT1
    Gayathri Manokaran, Michelle D. Audsley, Haruka Funakoda, Cassandra T. David, Katherine A. Garnham, Stephen M. Rawlinson, Céline Deffrasnes, Naoto Ito, Gregory W. Moseley · 2022 · PLoS Pathogens
39. The Role of Interferons in Long Covid Infection
    Mohammad Karbalaeimahdi, Safar Farajnia, Nasrin Bargahi, Farzaneh Ghadiri Moghaddam, Hamid Reza Rasouli Jazi, Nasim Bakhtiari, Samaneh Ghasemali, Nosratollah Zarghami · 2023 · Journal of Interferon & Cytokine Research
40. Improved understanding of biorisk for research involving microbial modification using annotated sequences of concern
    Gene D. Godbold, F. Curtis Hewitt, Anthony D. Kappell, Matthew B. Scholz, Stacy L. Agar, Todd J. Treangen, Krista L. Ternus, Jonas B. Sandbrink, Gregory D. Koblentz · 2023 · Frontiers in Bioengineering and Biotechnology
41. SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA
    Aixin Li, Bei Zhang, Kaitao Zhao, Zhinang Yin, Yan Teng, Lu Zhang, Zaichao Xu, Kaiwei Liang, Xiaoming Cheng, Yuchen Xia · 2023 · Journal of Virology
42. Transcriptional Profiling of SARS-CoV-2-Infected Calu-3 Cells Reveals Immune-Related Signaling Pathways
    Eric Petterson Viana Pereira, Stela Mirla da Silva Felipe, Raquel Martins de Freitas, José Ednésio da Cruz Freire, Antônio Edson Rocha Oliveira, Natália do Vale Canabrava, Paula Matias Soares, Maurício Fraga van Tilburg, Maria Izabel Florindo Guedes, Chad Eric Grueter et al. · 2023 · Pathogens
43. Mutational analysis of SARS-CoV-2 ORF6-KPNA2 binding interface and identification of potent small molecule inhibitors to recuse the host immune system
    Muhammad Suleman, Afsheen Said, Haji Khan, Shoaib Ur Rehman, Abdulrahman Alshammari, Sérgio Crovella, Hadi Mohamad Yassine · 2024 · Frontiers in Immunology
44. New onset or recurrence of uveitis following COVID-19 infection
    Hui Feng, Meng Zhao, Jing Mo, Xusheng Cao, Weixin Chen, Hong Wang · 2024 · BMC Ophthalmology
45. SARS-CoV-2 Protein Nsp9 Is Involved in Viral Evasion through Interactions with Innate Immune Pathways
    Eryn Lundrigan, Caroline Toudic, Emily Pennock, John Paul Pezacki · 2024 · ACS Omega
46. A glimpse into viral warfare: decoding the intriguing role of highly pathogenic coronavirus proteins in apoptosis regulation
    Leyi Cheng, Yajuan Rui, Yanpu Wang, Shiqi Chen, Jiaming Su, Xiao‐Fang Yu · 2024 · Journal of Biomedical Science
47. Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses
    Thomas Kehrer, Adolfo García‐Sastre, Lisa Miorin · 2021 · Journal of Interferon & Cytokine Research
48. Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2-infected cells
    Manon Venet, Margarida Sá Ribeiro, Élodie Décembre, Alicia Bellomo, Garima Joshi, Marine Villard, David Cluet, Magali Perret, Rémi Pescamona, Helena Païdassi et al. · 2021 · medRxiv
49. FHL2 Inhibits SARS-CoV-2 Replication by Enhancing IFN-β Expression through Regulating IRF-3
    Zhiqiang Xu, Mingyao Tian, Qihan Tan, Pengfei Hao, Zihan Gao, Chang Li, Ningyi Jin · 2023 · International Journal of Molecular Sciences
50. STAT3 Increases CVB3 Replication and Acute Pancreatitis and Myocarditis Pathology via Impeding Nuclear Translocation of STAT1 and Interferon-Stimulated Gene Expression
    Tianming Liang, Zhipeng Zhang, Zhenxin Bai, Le Xu, Wei Xu · 2024 · International Journal of Molecular Sciences
51. A comprehensive review of current insights into the virulence factors of SARS-CoV-2
    Yi Wang, Bingqing Xia, Zhaobing Gao · 2025 · Journal of Virology
52. Pattern Recognition Receptors (PRRs) Expression and Activation in COVID-19 and Long COVID: From SARS-CoV-2 Escape Mechanisms to Emerging PRR-Targeted Immunotherapies
    Luca Maddaloni, Ginevra Bugani, Matteo Fracella, Camilla Bitossi, Alessandra D’Auria, Francesca Aloisi, Abir Azri, Letizia Santinelli, Manel Ben M’hadheb-Gharbi, Alessandra Pierangeli et al. · 2025 · Microorganisms
53. Innate Immune Responses and Pulmonary Diseases
    Tao Liu, Siqi Liu, Xiaobo Zhou · 2021 · Advances in experimental medicine and biology
54. When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak
    Yassine Taoufik, Marie-Ghislaine de Goër de Herve, Stéphanie Corgnac, Antoine Dürrbach, Fathia Mami‐Chouaib · 2021 · Frontiers in Immunology
55. Interaction between Sars-CoV-2 structural proteins and host cellular receptors: From basic mechanisms to clinical perspectives
    Henry Wade, Qihua Duan, Qiaozhu Su · 2022 · Advances in protein chemistry and structural biology
56. Cysteamine-mediated blockade of the glycine cleavage system modulates epithelial cell inflammatory and innate immune responses to viral infection
    Douglas J. Fraser-Pitt, Derry K. Mercer, Marie-Louise R. Francis, David Toledo-Aparicio, Daniel W. Smith, Deborah A. O′Neil · 2023 · Biochemical and Biophysical Research Communications
57. Safety and feasibility of third-party cytotoxic T lymphocytes for high-risk patients with COVID-19
    Dolores A. Grosso, J. Wagner, Allyson O'Connor, Kaitlyn Keck, Yan-Ping Huang, Zi-Xuan Wang, Hilary Mehler, Benjamin Leiby, P. Flomenberg, U. Gergis et al. · 2024 · Blood Advances
58. Targeting Myeloid Differentiation Primary Response Protein 88 (MyD88) and Galectin-3 to Develop Broad-Spectrum Host-Mediated Therapeutics against SARS-CoV-2
    Kamal U. Saikh, Khairul Anam, Halima Sultana, Rakin Ahmed, Simran Kumar, Sanjay Srinivasan, Hafiz Ahmed · 2024 · International Journal of Molecular Sciences
59. Mechanisms of host type I interferon response modulation by the nucleocapsid proteins of alpha- and betacoronaviruses
    Priya Yelemali, Lin Hao, Qiang Liu · 2022 · Archives of Virology
60. Antigenic Determinants of SARS-CoV-2-Specific CD4+ T Cell Lines Reveals M Protein-Driven Dysregulation of Interferon Signaling
    Pedro Henrique Gazzinelli-Guimarães, Gayatri Sanku, Alessandro Sette, Daniela Weiskopf, Paul Schaughency, Justin Lack, Thomas B. Nutman · 2022 · Frontiers in Immunology
61. Imaging Techniques: Essential Tools for the Study of SARS-CoV-2 Infection
    Aurélie Deroubaix, Anna Kramvis · 2022 · Frontiers in Cellular and Infection Microbiology
62. An Insight Into Pathophysiology, Epidemiology, and Management of Cardiovascular Complications of SARS-CoV-2 Infection, Post-acute COVID Syndrome, and COVID Vaccine
    Farideh Davoudi, Satoshi Miyashita, Tae Kyung Yoo, Patrick T. Lee, Gabriel P. Foster · 2022 · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine
63. Molecular cloning, expression and functional analysis of STAT2 in orange-spotted grouper, Epinephelus coioides
    Yinghui Qin, Haixiang Liu, Peipei Zhang, Si Deng, Reng Qiu, Lunguang Yao · 2022 · Fish & Shellfish Immunology
64. Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19
    Agustı́n Valenzuela-Fernández, Romina Cabrera-Rodríguez, Laura Ciuffreda, Silvia Pérez-Yanes, Judith Estévez‐Herrera, Rafaela González‐Montelongo, Julia Alcoba-Flórez, Rodrigo Trujillo‐González, Diego García-Martínez de Artola, Helena Gil-Campesino et al. · 2022 · Frontiers in Bioengineering and Biotechnology
65. Robustness of FTIR-Based Ultrarapid COVID-19 Diagnosis Using PLS-DA
    Sreejith Remanan Pushpa, Rajeev Kumar Sukumaran, Sivaraman Savithri · 2022 · ACS Omega
66. SARS-CoV-2-free residual proteins mediated phenotypic and metabolic changes in peripheral blood monocytic-derived macrophages in support of viral pathogenesis
    Mohammad G. Mohammad, Naglaa S. Ashmawy, Ahmed M. Al-Rawi, Ameera Abu-Qiyas, Alshaimaa M. Hamoda, Rania Hamdy, Salam Dakalbab, Shahad Arikat, Dana Salahat, Mohamed Ibrahim Madkour et al. · 2023 · PLoS ONE
67. Cellular Sensors and Viral Countermeasures: A Molecular Arms Race between Host and SARS-CoV-2
    Haoran Sun, J. Chan, Shuo-Feng Yuan · 2023 · Viruses
68. Profile of SARS-CoV-2
    Franz Xaver Heinz, Karin Stiasny · 2020 · Wiener klinische Wochenschrift
69. Inhaled interferons beta and SARS-COV2 infection: a preliminary therapeutic perspective
    Elena Cojocaru, Cristian Cojocaru, Sabina A Antoniu, Celina Silvia Stafie, Armand Gabriel Râjnoveanu, Ruxandra Râjnoveanu · 2021 · Expert Review of Respiratory Medicine
70. Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease
    Anna Allué‐Guardia, Jordi Bertran Torrelles, Alex Sigal · 2023 · Frontiers in Immunology
71. CNBP restricts SARS-CoV2 by regulating IFN and disrupting RNA-protein condensates
    Katherine A. Fitzgerald, Yongzhi Chen, Xuqiu Lei, Zhaozhao Jiang, Fiachra Humphries, Nicholas Mustone, Irene Ramos, Tinaye Mutetwa, Ana Fernández-Sesma · 2022 · Research Square
72. Induction of the Inflammasome by the SARS‐CoV‐2 Accessory Protein ORF9b, Abrogated by Small‐Molecule ORF9b Homodimerization Inhibitors
    Erika Zodda, Mònica Pons, Natàlia DeMoya‐Valenzuela, Cristina Calvo‐González, Cristina Benítez‐Rodríguez, Blanca Dies López-Ayllón, Achraf Hibot, Alice Zuin, Bernat Crosas, Marta Cascante et al. · 2025 · Journal of Medical Virology
73. Development of SARS-CoV-2 as a viral vector: A novel intranasal bivalent vaccine for SARS-CoV-2 and RSV
    Jiayu Xu, Michelle Chamblee, Fei Jiang, Mahesh KC, Cheng Chih Hsu, Ilada Thongpan, Phylip Chen, Yuexiu Zhang, Chun-Ta Chiu, Mohamed M. Shamseldin et al. · 2025 · Science Advances
74. Regulating the microenvironment with nanomaterials: Potential strategies to ameliorate COVID-19
    Zhicheng Liu, Zhuolei Han, Xin Jin, Jusung An, Jaewon Kim, Wenting Chen, Jong Seung Kim, Ji Zheng, Jun Deng · 2023 · Acta Pharmaceutica Sinica B
75. Interferon-lambda: New functions on intestinal symptoms in COVID-19
    Yiyang Pan, Liu-Can Wang, Feng Yang, Min Yu · 2023 · World Journal of Gastroenterology
76. COVID-19. Biology, pathophysiology, and immunology: a pathologist view
    Marco Chilosi, Claudio Doglioni, Claudia Ravaglia, Sara Piciucchi, Alessandra Dubini, Lavinia Stefanizzi, Venerino E. Poletti · 2023 · Pathologica
77. Elucidating the binding mechanism of SARS-CoV-2 NSP6-TBK1 and structure-based designing of phytocompounds inhibitors for instigating the host immune response
    Muhammad Suleman, Iqra Ishaq, Haji Khan, Safir Ullah Khan, Rehana Masood, Norah Abdullah Albekairi, Abdulrahman Alshammari, Sérgio Crovella · 2024 · Frontiers in Chemistry
78. Epigenetic repression of antiviral genes by SARS-CoV-2 NSP1
    Dimitrios G. Anastasakis, Daniel Benhalevy, Nicolas Çuburu, Nihal Altan‐Bonnet, Markus Hafner · 2024 · PLoS ONE
79. HCoV-229E Mpro Suppresses RLR-Mediated Innate Immune Signalling Through Cleavage of NEMO and Through Other Mechanisms
    Xavier Martiáñez–Vendrell, Puck B. van Kasteren, Sebenzile K. Myeni, Marjolein Kikkert · 2025 · International Journal of Molecular Sciences
80. Immune modulation: the key to combat SARS-CoV-2 induced myocardial injury
    Zhaoqing Li, Luning Qin, Xiaojian Xu, Ruolan Chen, Guoliang Zhang, Banghui Wang, Bing Li, Xian‐Ming Chu · 2025 · Frontiers in Immunology
81. How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review
    Qian Wang, Xing Wu, Qun-Ying Mao, Fan Gao, Mingchen Liu, Ziyang Song, Lian-Lian Bian, Zheng-Lun Liang · 2022 · Expert Review of Anti-Infective Therapy
82. Exploiting Extracellular Vesicles Strategies to Modulate Cell Death and Inflammation in COVID-19
    B. Bortot, Arianna Romani, Giuseppe Ricci, S. Biffi · 2022 · Frontiers in Pharmacology
83. Appraisal of SARS-CoV-2 mutations and their impact on vaccination efficacy: an overview
    Nastaran Hadizadeh, Mousa Naderi, Jafar Khezri, Meysam Yazdani, Mehdi Shamsara, Ehsan Hashemi · 2022 · Journal of Diabetes & Metabolic Disorders
84. SARS-CoV-2 Nucleocapsid Protein Has DNA-Melting and Strand-Annealing Activities With Different Properties From SARS-CoV-2 Nsp13
    Bo Zhang, Yan Xie, Zhaoling Lan, Dayu Li, Junjie Tian, Qintao Zhang, Hongji Tian, Jiali Yang, Xinnan Zhou, Shuyi Qiu et al. · 2022 · Frontiers in Microbiology
85. Endemicity Is Not a Victory: The Unmitigated Downside Risks of Widespread SARS-CoV-2 Transmission
    Madison Stoddard, Alexander Novokhodko, Sharanya Sarkar, Debra Van Egeren, Laura Forsberg White, Natasha S. Hochberg, Michael S. Rogers, Bruce R. Zetter, Diane Joseph‐McCarthy, Arijit Chakravarty · 2022 · COVID
86. Single-cell RNA-sequencing data analysis reveals a highly correlated triphasic transcriptional response to SARS-CoV-2 infection
    Pablo Andrés Gutiérrez Sánchez, Santiago F. Elena · 2022 · Communications Biology
87. SARS-CoV-2 Variants Show Different Host Cell Proteome Profiles With Delayed Immune Response Activation in Omicron-Infected Cells
    Melinda Metzler, Rebecca George Tharyan, Kevin Klann, Katharina Grikscheit, Denisa Bojková, Jindrich Jr. Cinatl, Georg Tascher, Sandra Ciesek, Christian Münch · 2023 · Molecular & Cellular Proteomics
88. Genetic characteristics of SARS-CoV-2 virus variants observed upon three waves of the COVID-19 pandemic in Ukraine between February 2021–January 2022
    G. V. Gerashchenko, Nataliya V. Hryshchenko, Nataliia Melnichuk, Tetiana Marchyshak, Serhii Yu Chernushyn, Irina V. Demchyshina, L. M. Chernenko, Ihor Kuzin, Zenovii Yu. Tkachuk, Vladimir I. Kashuba et al. · 2024 · Heliyon
89. Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint
    Marika Alborghetti, Gianmarco Bellucci, Antonietta Gentile, Chiara Calderoni, Ferdinando Nicoletti, Ruggero Capra, Marco Salvetti, Diego Centonze · 2021 · Current Neuropharmacology
90. Network Topology of Biological Aging and Geroscience-Guided Approaches to COVID-19
    ALAN L. LANDAY, Jenna M. Bartley, Dishary Banerjee, Geneva R. Hargis, Laura Haynes, Ali Keshavarzian, Chia‐Ling Kuo, Oh Sung Kwon, Sheng Li, Shuzhao Li et al. · 2021 · Frontiers in Aging
91. Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway
    Jian Chen, Jian Liu, Zhilu Chen, Haoran Peng, Cuisong Zhu, Daobin Feng, Shuye Zhang, Ping Zhao, Xiaoyan Zhang, Jianqing Xu · 2022 · mSphere
92. Analysis of co-occurring and mutually exclusive amino acid changes and detection of convergent and divergent evolution events in SARS-CoV-2
    Ruba Al Khalaf, Anna Bernasconi, Pietro Pinoli, Stefano Ceri · 2022 · Computational and Structural Biotechnology Journal
93. Electrically regulated cell‐based intervention for viral infections
    Sherri L. Newmyer, Marvin A. Ssemadaali, Harikrishnan Radhakrishnan, Harold S. Javitz, Parijat Bhatnagar · 2022 · Bioengineering & Translational Medicine
94. Promising Immunotherapies against COVID‐19
    Haodong Guo, Lili Zhou, Zhenyu Ma, Zhixin Tian, Fangfang Zhou · 2021 · Advanced Therapeutics
95. Antiviral T-cell Biofactory platform for SARS-CoV-2
    Marvin A. Ssemadaali, Sherri L. Newmyer, Harikrishnan Radhakrishnan, Juan Arredondo, Harold S. Javitz, Satya Dandekar, Parijat Bhatnagar · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
96. PARP14-dependent ADP-ribosylation of cytoplasmic SQSTM1/p62 foci supports innate immune signaling
    David Kubon, Sudharshana Sundaresan, Diyaraj Nadarajan, Deena M. Leslie Pedrioli, Michael O. Hottiger · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
97. A conserved methyltransferase active site residue of Zika virus NS5 is required for the restriction of STING activation and interferon expression
    Yuting Li, Zhaoxin Li, Haimei Zou, Peiwen Zhou, Yuhang Huo, Yaohua Fan, Xiaohong Liu, Jianguo Wu, Geng Li, Xiao Wang · 2024 · Journal of General Virology
98. Origin and function of anti-interferon type I viral proteins
    Marta Acchioni, Chiara Acchioni, John B. Hiscott, Marco Sgarbanti · 2025 · Virology
99. Early innate immune response and evolution of a SARS-CoV-2 furin cleavage site inactive variant in bat cells
    Kaushal Baid, Sauhard Shrivastava, Jessica Luc, Daniel J. Richard, Jennifer A. Aguiar, Yoan J. Machado, Sophie‐Marie Aicher, Kimberley C. Siwak, Emmanuelle V. LeBlanc, Zahed Khatooni et al. · 2025 · Cell Reports
100. The role of SARS-CoV-2 main protease in innate immune regulation: From molecular mechanisms to therapeutic implications
     Yumeng Gao, Jun Zhang · 2025 · Acta Pharmaceutica Sinica B